| 查看: 2958 | 回复: 29 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
ziqiangchem木虫 (正式写手)
|
[交流]
北京大学深圳研究生院黄湧老师课题组招聘助研已有11人参与
|
||
|
北京大学深圳研究生院黄湧老师课题组招聘助研、 化学基因组实验室:黄湧老师课题组招聘助研1-2名， 有机化学或药物化学专业本科或硕士毕业生，有一定实验经验者优先考虑有意者可发简历至邮箱tanghm@pkusz.edu.cn,或电话咨询：0755-26032127，13027972879 QQ:269584905 http://www.scbb.szpku.edu.cn/lab ... ?GID=20&UID=105 黄 湧博士 Principal Investigator, Pengcheng Professor Tel：+86-755-2603-5566 Fax：+86-755-2603-3174 E-mail：huangyong@szpku.edu.cn Web： 学习和工作经历 EDUCATION & EXPERIENCE 2009 – present Professor of Chemistry, Shenzhen Graduate School, Peking University 2004 – 2009 Senior Research Scientist, Merck Research Laboratories, Merck & Co., Rahway, NJ 2002 – 2004 Postdoctoral Scholar, California Institute of Technology, Pasadena, CA 1997 – 2002 M.Sc. and Ph.D., University of Chicago, Chicago, IL 1993 – 1997 B.Sc., Peking University FELLOWSHIPS AND AWARDS 2000 Lucent Technologies Travel Grant 2001 Abbott Laboratories Graduate Fellowship 2002 George van Dyke Tiers Travel Award 2002 Elisabeth R. Norton Prize for Excellence 研究方向 The group of Dr. Yong Huang has broad interest and extensive experiences in the areas of Medicinal Chemistry, Organic Synthesis, Asymmetric Catalysis and Organometallics. We hope to invent and bring the-state-of-the-art technologies and research strategies to help define a new paradigm in the fields of Chemistry and Chemical Biology. Our research focus includes, but not limited to, the following fields: 1. Total synthesis of biologically active natural products 2. Development of novel chemical transformations for organic synthesis, focusing on asymmetric catalysis 3. Drug discovery: medicinal chemistry from target validation to preclinical 发表论文和专利 SELECTIVE PUBLICATIONS 1. Avinash N.Thadani,Yong Huang,and Viresh H.Rawal., "Expedient,High-Yielding Synthesis of Silyl-Substituted Salen Ligands" Org.Lett., 2007, 9, 3873–3876. 2. Yong Huang, Abbas M.Walji, Catharine H. Larsen, and David W. C. MacMillan., "Enantioselective Organo-Cascade Catalysis" J.Am.Chem.Soc.; 2005; 127, 15051–15053.(100 Current “Hot” Papers, National Chemistry Week 2006; For the two consecutive times, rated as the No.1 most cited paper at JACS; Nature research highlight,Vol.437,2005,1068-1069) 3. Yong Huang, Aditya K. Unni, Avinash N. Thadani and Viresh H. Rawal., "Hydrogen Bonding to a Chiral Alcohol Catalyzes Highly Enantioselective Reactions" Nature, 2003, 424, 146. (C&EN Headline, July 14, 2003) 4. Norito Takenaka,Yong Huang,and Viresh H.Rawal.,"The First Catalytic Enantioselective Diels-Alder Reactions of 1,2- Dihydropyridine: Efficient Syntheses of Optically Active 2-Azabicyclo [2.2.2]octanes with Chiral BINAM Derived Cr(III) Salen Complexes" Tetrahedron, 2002, 58, 8299-8305. 5. Yong Huang and Viresh H. Rawal., "Hydrogen Bond Promoted Hetero Diels-Alder Reactions of Ketones" J.Am.Chem.Soc., 2002, 124, 9662-9663. 6. Yong Huang, Tetsuo Iwama, and Viresh H. Rawal., "Design and Development of Highly Effective Lewis Acid Catalysts for Enantioselective Diels-Alder Reactions" J.Am.Chem. Soc.,2002,124,5950-5951. 7. Sergey A. Kozmin, Tetsuo Iwama, Yong Huang, and Viresh H. Rawal., "An Efficient Approach to Aspidosperma Alkaloids via [4+2] Cycloadditions of Aminosiloxydienes: Stereocontrolled Total Synthesis of (±)-Tabersonine. Gram-Scale Catalytic Asymmetric Syntheses of (+)- Tabersonine and (+)-16-Methoxytabersonine. Asymmetric Syntheses of (+)-Aspidospermidine and (-)-Quebrachamine" J.Am.Chem.Soc., 2002, 124,4628-4641. 8. Yong Huang, Tetsuo Iwama,and Viresh H. Rawal., "Broadly Effective Enantioselective Diels-Alder Reactions of 1-Amino-substituted-1, 3-butadienes" Org.Lett. 2002, 4, 1163-1166. 9. Yong Huang, Tetsuo Iwama, and Viresh H. Rawal., "Highly Enantioselective Diels-Alder Reactions of 1-Amino-3-siloxy-dienes Catalyzed by Cr(III)-Salen Complexes" J.Am.Chem. Soc.,2000,122,7843-7844. 10. Yong Huang, Viresh. H. Rawal., "Hetero Diels-Alder Reactions of 1-Amino-3-Siloxy-1, 3-butadiene under Strictly Thermal Conditions" Org.Lett.2000,2,3321-3323. |
回复此楼» 猜你喜欢
博士读完未来一定会好吗
已经有23人回复
-
导师想让我从独立一作变成了共一第一
已经有7人回复
-
到新单位后，换了新的研究方向，没有团队，持续积累2区以上论文，能申请到面上吗
已经有11人回复
-
读博
已经有4人回复
-
JMPT 期刊投稿流程
已经有4人回复
-
心脉受损
已经有5人回复
-
Springer期刊投稿求助
已经有4人回复
-
小论文投稿
已经有3人回复
-
申请2026年博士
已经有6人回复
顶 |
4楼2010-06-10 14:49:00